VSIR and neoplasm: Given that the PSGL-1/VISTA interaction only occurs at an acidic pH [7], these data suggest that decreases in glycolytic genes and PSGL-1 may work in concert to improve anti-tumor immune responses upon targeting mTORC2 in LUSC tumors.